SCHEMBL20144187

SCHEMBL20144187

CC(C)OC(=O)CNP(OCC1CCC(c2ccc3c(N)ncnn23)O1)Oc1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ DOT1L Q8TEK3 2/20 0.34
▸ RIPK1 Q13546 3/20 0.32
▸ TNK2 Q07912 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24057868 1.00 DOT1L (0.34) DOT1LRIPK1TNK2
SCHEMBL24158150 0.89 DOT1L (0.33) DOT1LTNK2
SCHEMBL20834801 0.88 DOT1L (0.34) DOT1LRIPK1TNK2
SCHEMBL24058189 0.86 DOT1L (0.33) DOT1L
SCHEMBL20882129 0.85 DOT1L (0.33) DOT1LRIPK1
SCHEMBL24149121 0.84 DOT1L (0.34) DOT1L
SCHEMBL20834874 0.83 DOT1L (0.33) DOT1LRIPK1
SCHEMBL22355532 0.83 BTN3A1 (0.34) DOT1LRIPK1
SCHEMBL24158267 0.83 DOT1L (0.34) DOT1LRIPK1
SCHEMBL24148995 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021154687-A1 METHODS FOR TREATING SARS COV-2 INFECTIONS GILEAD SCIENCES, INC. (US) 2021-08-05 — — WO disclosed
EP-3212174-B1 METHODS FOR TREATING FILOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES INC (US) 2018-05-16 — — EP disclosed
Send feedback